Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00339833Phase 4Completed
A Phase 4 trial of Amigesic in type 2 diabetes mellitus (T2DM), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Mar 2003; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00339833.